Vericel Corporation
VCEL

$2.8 B
Marketcap
$56.71
Share price
Country
$2.36
Change (1 day)
$59.17
Year High
$32.31
Year Low
Categories

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

marketcap

Revenue of Vericel Corporation (VCEL)

Revenue in 2023 (TTM): $197.52 M

According to Vericel Corporation's latest financial reports the company's current revenue (TTM) is $197.52 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Vericel Corporation

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $197.52 M $135.58 M $2.86 M $-2,368,000 $-3,182,000
2022 $164.37 M $109.79 M $-11,641,000 $-15,988,000 $-16,709,000
2021 $156.18 M $106.03 M $-4,613,000 $-7,582,000 $-7,471,000
2020 $124.18 M $84.23 M $9.88 M $3.04 M $2.86 M
2019 $117.85 M $80.28 M $-5,126,000 $-9,665,000 $-7,909,000
2018 $90.86 M $58.7 M $-4,979,000 $-8,137,000 $-8,137,000
2017 $63.92 M $33.57 M $-14,567,000 $-17,286,000 $-17,286,000
2016 $54.38 M $26.08 M $-17,366,000 $-19,566,000 $-19,566,000
2015 $51.17 M $24.7 M $-14,739,000 $-16,340,000 $-16,340,000
2014 $28.8 M $11.5 M $-19,162,000 $-19,920,000 $-19,920,000
2013 $19 K $15 K $-15,122,000 $-15,622,000 $-15,622,000
2012 $21 K $15 K $-28,813,000 $-29,474,000 $-29,474,000
2011 $18 K $14 K $-19,011,000 $-19,711,000 $-19,668,000
2010 $89 K $55 K $-30,148,000 $-17,729,000 $-17,729,000
2009 $182 K $70 K $-17,804,000 $-15,946,000 $-15,946,000
2008 $522 K $466 K $-15,465,000 $-20,133,000 $-20,133,000
2007 $685 K $656 K $-21,219,000 $-16,475,000 $-17,594,000
2006 $863 K $852 K $-19,469,000 $-11,811,000 $-16,475,000
2005 $909 K $761 K $-17,733,000 $-12,405,000 $-11,811,000
2004 $1.3 M $1.02 M $-12,417,000 $-10,488,000 $-10,488,000
2003 $844 K $-49,000 $-10,363,000 $-9,579,000 $-9,579,000
2002 $877 K $675 K $-9,713,000 $-7,939,000 $-7,939,000
2001 $899 K $886 K $-8,155,000 $-9,390,000 $-5,926,000
2000 $1.15 M $224 K $-6,477,000 $-9,390,000 $-9,390,000
1999 $881 K $875 K $-9,429,000 $-11,595,000 $-11,028,000
1998 $249 K $249 K $-12,619,000 $ $-17,233,000
1997 $400 K $900 K $-17,751,000 $-14,300,000 $-14,300,000
1996 $1.6 M $-8,000,000 $-14,500,000 $-9,800,000 $-9,900,000